Inventor · disambiguated record
Rowchanak Pakdaman
Also filed as: PAKDAMAN ROWCHANAK
8 granted patents·5 pending applications·187 citations·filing 2012–2019
87Inventor score
Top patents by PatentIndex Score
13 records- 0195US9549941B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 24, 2017·39 cites·23 claims
- 0295US8889159B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2012·Granted Nov 18, 2014·114 cites·37 claims
- 0391US9382256B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Jul 5, 2016·17 cites·57 claims
- 0488US9949932B2Formulation of syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Apr 24, 2018·8 cites·14 claims
- 0585US9918939B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Mar 20, 2018·8 cites·23 claims
- 0675US10039779B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 7, 2018·1 cites·16 claims
- 0774US2020188419A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 0861US2019111068A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 0960US2014212491A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 1058US2017348342A1Compositions and methods for treating hepatitis c virusGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 1156US10912814B2Combination formulation of three antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Feb 9, 2021·0 cites·2 claims
- 1253US11338007B2Combination formulation of three antiviral compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 24, 2022·0 cites·44 claims
- 1353US2016120892A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rowchanak Pakdaman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →